drugset / Trial / NCT01337557
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-09
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bepotastine | Small molecule | 1.5 % | Other |